Comprehensive transcriptome analysis of peripheral blood unravels key lncRNAs implicated in ABPA and asthma

Chen Huang1,2, Dongliang Leng3, Peiyan Zheng4

  • 1Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, Macau University of Science and Technology, Macau, SAR, China, Macau, China.

Peerj
|July 5, 2021
PubMed

Insights

This study identifies key lncRNAs involved in allergic bronchopulmonary aspergillosis (ABPA) and asthma by analyzing blood transcriptomes. Repressed expression of these lncRNAs suggests their role in immune responses for both conditions.

Area of Science:

  • Pulmonary Immunology
  • Molecular Biology
  • Transcriptomics

Background:

  • Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease caused by *Aspergillus fumigatus*.
  • ABPA complicates and worsens asthma, but the mechanisms linking asthma to ABPA are unclear.

Purpose of the Study:

  • To identify crucial long non-coding RNAs (lncRNAs) associated with ABPA and asthma.
  • To explore the relationship and pathogenic mechanisms between ABPA and asthma.

Main Methods:

  • Integrative transcriptome analysis of human peripheral blood from ABPA patients, asthmatic patients, and healthy controls.
  • Stringent filtering pipeline for lncRNA identification.
  • Differential expression and network analysis to identify key lncRNAs and their roles.

Main Results:

  • Identified several immune-related mRNAs and lncRNAs differentially expressed in ABPA and asthma.
  • Discovered key lncRNAs (e.g., AL139423.1-201, AC106028.4-201) implicated in ABPA and asthma.
  • Found that these lncRNAs are part of loss-of-function networks and show repressed expression in both diseases.

Conclusions:

  • The identified lncRNAs play significant roles in immune-related processes during ABPA and asthma.
  • This research offers a new perspective on the ABPA-asthma relationship and potential pathogenic mechanisms.